Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Strutture
  • Competenze

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Strutture
  • Competenze
  1. Pubblicazioni

CANCER IMMUNOLOGY AND IMMUNOTHERAPY

Rivista
Codice:
E032027
ISSN:
0340-7004
  • Dati Generali

Dati Generali

Pubblicazioni (14)

  • ascendente
  • decrescente
A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment
Articolo
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers
Articolo
Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression
Articolo
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery.
Articolo
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
Articolo
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma (vol 63, pg 675, 2014)
Articolo
Influence of low- dose beta interferon on natural killer activity in breast cancer patients subjected to chemotherapy.
Articolo
Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer-and lymphokine-activated-killer-mediated cytotoxicity
Articolo
Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach
Articolo
Progression mechanisms in colon cancer: soluble interleukin2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and
Articolo
Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer.
Articolo
The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24-26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy
Articolo
The Significance of an increase in soluble interleukin- 2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 o TH2 and back.
Articolo
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)